An autologous hemostatic agent
James, A.G.; Zollinger, R.W.
Surgery Gynecology and Obstetrics 159(4): 381-382
1984
ISSN/ISBN: 0039-6087 PMID: 6484796 Document Number: 224855
The use of autologous muscle as a thromboplastic agent in operations upon the head and neck has proved to be a safe, cost effective means to accomplish hemostasis in an area where it is absolutely necessary.
Document emailed within 1 workday
Related Documents
Giele, H. 1994: Histoacryl glue as a hemostatic agent in microvascular anastomoses Plastic and Reconstructive Surgery 94(6): 897Carroll, J.F.; Moskowitz, K.A.; Edwards, N.M.; Hickey, T.J.; Rose, E.A.; Budzynski, A.Z. 1996: Immunologic assessment of patients treated with bovine fibrin as a hemostatic agent Thrombosis and Haemostasis 76(6): 925-931
Conlan, M.G.; Haire, W.D.; Kessinger, A.; Armitage, J.O. 1991: Prothrombotic hemostatic abnormalities in patients with refractory malignant lymphoma presenting for autologous stem cell transplantation Bone Marrow Transplantation 7(6): 475-479
Gazzeri, R.; Neroni, M.; Pischedda, M.; Martin, M.; Galarza, M.; Campagna, D.; Giordano, M. 2015: A Clinico-pathologic Study of Oxidized Cellulose as Topical Hemostatic Agent in Neurosurgery Surgical Technology International 26: 376-381
Singh, R.P.; Maheshwari, V.; Verma, A.K. 2008: Evaluation of gelatin/resorcinol/aldehyde as a hemostatic agent and tissue adhesive: an experimental study in rat International Surgery 93(1): 25-31
Hanne, H.; Schröder, F. 1980: Clinical experience with the treatment of extraction wounds with a specific, resorbable, local hemostatic agent Zwr 89(12): 51
McNamara, P.S.; Barr, S.C.; Erb, H.N. 1996: Hematologic, hemostatic, and biochemical effects in dogs receiving an oral chondroprotective agent for thirty days American Journal of Veterinary Research 57(9): 1390-1394
Gultekin, M.; Diribaş, K.; Buru, E.; Gökçeoğlu, M.A. 2009: Role of a non-hormonal oral anti-fibrinolytic hemostatic agent (tranexamic acid) for management of patients with dysfunctional uterine bleeding Clinical and Experimental Obstetrics and Gynecology 36(3): 163-165
Hernández, M.D.; del Cañizo, M.C.; González, M.; Caballero, M.D.; López-Berges, M.C.; Vázquez, L.; Orfao, A.; Corral, M.; Nieto, M.J.; San Miguel, J.F. 1998: Immune reconstitution after autologous progenitor hemopoietic cell transplantation. a study comparing autologous bone marrow and autologous peripheral blood transplantation Medicina Clinica 110(20): 768-773
Lopez, M.; Mortel, O.; Pouillart, P.; Zucker, J.M.; Fechtenbaum, J.; Douay, L.; Palangie, T.; Michon, J.; Salmon, D. 1990: Infusion of autologous peripheral blood nucleated cells hastens hematological recovery after high dose chemotherapy and autologous transplantation of bone marrow Bone Marrow Transplantation 5 Suppl. 1: 44-45
Bacenková, D.; Rosocha, J.; Svihla, R.; Vasko, G.; Bodnár, J. 2001: Repair of chondral defects of the knee using a combination of autologous chondrocytes and osteochondral allograft--an animal model. Part I: in vitro culture of autologous chondrocytes Acta Chirurgiae Orthopaedicae et Traumatologiae Cechoslovaca 68(6): 363-368
Hoover, H.C.; Surdyke, M.; Dangel, R.B.; Peters, L.C.; Hanna, M.G. 1984: Delayed cutaneous hypersensitivity to autologous tumor cells in colorectal cancer patients immunized with an autologous tumor cell: Bacillus Calmette-Guérin vaccine Cancer Research 44(4): 1671-1676
Hollán, Z. 1986: Is the HTLV III/LAV virus the causative agent of AIDS or merely an agent of one of the opportunistic infections? Orvosi Hetilap 127(52): 3219-3220
Rider, J.A. 1976: Small bowel motility: comparison of the effects of an anticholinergic agent, this agent plus a tranquilizer, and a placebo Current Therapeutic Research 20(2): 142-148
Short, C.E.; Miller, R.L. 1978: Comparative evaluation of the anticholinergic agent glycopyrrolate as a preanesthetic agent Veterinary Medicine-Small Animal Clinician 73(10): 1269-1273
Ziebolz, D.; Hannig, C.; Attin, T. 2008: Influence of a desensitizing agent on efficacy of a paint-on bleaching agent American Journal of Dentistry 21(2): 77-82
Naess, K. 1973: A beta blocking agent as an antihypertensive agent Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 93(27): 2041
Fegan, C.; Thomas, H.; Bailey-Wood, R.; Coleman, S.; Phillips, S.; Hoy, T.; Whittaker, J.A. 1995: In vitro LAK (lymphokine activated killer) activity following autologous peripheral blood stem cell is significantly greater than that following autologous bone marrow and allogeneic bone marrow transplantation Bone Marrow Transplantation 16(2): 277-281
El-Fiky, S.M.; Fahmy, T.Y.; Ameen, A.M. 1971: Morpho-topochemical studies of Golgi apparatus and Vitamin C in normal mammary gland cells of agent free C3Hf and agent carrying the MTV in C3H mouse strain Acta Histochemica 41(1): 131-136
Wied, G.L.; Davis, M.E. 1959: A new orally effective progestational agent: increased effectiveness in the human of a progestational agent by attaching a methyl-group at carbon position six of the steroid ring Obstetrics and Gynecology 14: 305-308